Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Multicenter Trial to Study the Efficacy and Safety of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura

NCT04074187 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT04074187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04074187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Multicenter Trial to Study the Efficacy and Safety of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura
Lead sponsor
Sanofi
Phase
Phase 2/3
Overall status
Completed
Start date
October 21, 2019
Completion date
May 19, 2021
Enrollment
21 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

thrombotic thrombocytopenic purpura